acetaminophen has been researched along with oxidopamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Hole, K; Lund, A; Tjølsen, A | 1 |
| Caldwell, GA; Caldwell, KA; Fox, SA; Locke, CJ | 1 |
3 other study(ies) available for acetaminophen and oxidopamine
| Article | Year |
|---|---|
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems.
Topics: 5,6-Dihydroxytryptamine; Acetaminophen; Analgesics; Animals; Behavior, Animal; Hydroxydopamines; Injections, Spinal; Male; Motor Activity; Oxidopamine; Pain Measurement; Rats; Rats, Inbred Strains; Serotonin; Spinal Cord | 1991 |
Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease.
Topics: Acetaminophen; Adrenergic Agents; alpha-Synuclein; Analgesics, Non-Narcotic; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Cell Count; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Gene Expression Regulation; Green Fluorescent Proteins; Neurodegenerative Diseases; Neurons; Oxidopamine; Parkinson Disease; Tyrosine 3-Monooxygenase | 2008 |